| A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity H Kadry, B Noorani, L Cucullo Fluids and Barriers of the CNS 17, 1-24, 2020 | 1220 | 2020 |
| Digital light processing (DLP) 3D-printing technology and photoreactive polymers in fabrication of modified-release tablets H Kadry, S Wadnap, C Xu, F Ahsan European Journal of Pharmaceutical Sciences 135, 60-67, 2019 | 296 | 2019 |
| Multi-purposable filaments of HPMC for 3D printing of medications with tailored drug release and timed-absorption H Kadry, TA Al-Hilal, A Keshavarz, F Alam, C Xu, A Joy, F Ahsan International journal of pharmaceutics 544 (1), 285-296, 2018 | 155 | 2018 |
| Newer approaches and novel drugs for inhalational therapy for pulmonary arterial hypertension A Keshavarz, H Kadry, A Alobaida, F Ahsan Expert opinion on drug delivery 17 (4), 439-461, 2020 | 44 | 2020 |
| Pulmonary-arterial-hypertension (PAH)-on-a-chip: fabrication, validation and application TA Al-Hilal, A Keshavarz, H Kadry, B Lahooti, A Al-Obaida, Z Ding, W Li, ... Lab on a Chip 20 (18), 3334-3345, 2020 | 33 | 2020 |
| A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS 17 (1): 69 H Kadry, B Noorani, L Cucullo BioMed Central Ltd. https://doi. org/10.1186/s12987-020-00230-3 17, 1-24, 2020 | 23 | 2020 |
| Comparative assessment of in vitro BBB tight junction integrity following exposure to cigarette smoke and e-cigarette vapor: a quantitative evaluation of the protective effects … H Kadry, B Noorani, U Bickel, TJ Abbruscato, L Cucullo Fluids and Barriers of the CNS 18 (1), 28, 2021 | 21 | 2021 |
| Statistical optimization and validation of a novel ultra-performance liquid chromatography method for estimation of nintedanib in rat and human plasma SK Shukla, H Kadry, JA Bhatt, R Elbatanony, F Ahsan, V Gupta Bioanalysis 12 (3), 159-174, 2020 | 11 | 2020 |
| Advanced microfluidic vascularized tissues as platform for the study of human diseases and drug development B Noorani, L Cucullo, Y Ahn, H Kadry, A Bhalerao, S Raut, E Nozohouri, ... Current Neuropharmacology 21 (3), 599-620, 2023 | 5 | 2023 |
| Method for Investigating FibroblastDurotaxis H Kadry, D Lagares, TA Al-Hilal Myofibroblasts: Methods and Protocols, 227-236, 2021 | 5 | 2021 |
| Evaluation of Barrier Integrity Using a Two-Layered Microfluidic Device Mimicking the Blood-Brain Barrier H Kadry, L Cucullo Vascular Hyperpermeability: Methods and Protocols, 77-88, 2023 | 3 | 2023 |
| A modelling approach to compare ADC deconjugation and systemic elimination rates of individual drug-load species using native ADC LC-MS data from human plasma SM Hengel, AR Topletz-Erickson, H Kadry, SC Alley Xenobiotica 54 (8), 492-501, 2024 | 1 | 2024 |
| Bioengineering approach for pulmonary drug delivery A Keshavarz, H Kadry, A Alobaida, M Nurunnabi, TA Al-Hilal Bioinspired and Biomimetic Materials for Drug Delivery, 241-276, 2021 | 1 | 2021 |
| Formulation and Optimization of Vardenafil Hydrochloride Oral Disintegrating Tablets: Effect of Superdisintegrants H Kadry, AA Zaky, AA Kassem Al-Azhar Journal of Pharmaceutical Sciences 53 (1), 39-57, 2016 | 1 | 2016 |
| Shukla-Nintedanib UPLC-Bioanalysis-2020. pdf S Shukla, H Kadry, J A Bhatt, R Elbatanony, F Ahsan, V Gupta Health Research Alliance, 2025 | | 2025 |
| On-Demand and Point-of-Care Printing of Tablets for Sustained Drug Delivery and Personalized Dosing H Kadry, S Wadnap, T Al-Hilal, C Xu, F Ahsan American Association of Pharmaceutical Sciences (AAPS), 2018 | | 2018 |
Luca CuculloOakland University William Beaumont School of Medicine/Beaumont Research Instituteoakland.edu의 이메일 확인됨